Bayer Shareholders Urge CEO to Accelerate Turnaround Amid Declining Shares
Bayer AG (BAYGn.DE) is under increasing pressure from its shareholders to quicken its turnaround efforts following a dramatic 14.5% drop in share value earlier this week....
Bayer AG (BAYGn.DE) is under increasing pressure from its shareholders to quicken its turnaround efforts following a dramatic 14.5% drop in share value earlier this week....
The Surge of Injectable GLP-1 Medications and Access Challenges In recent years, injectable medications such as Ozempic, Wegovy, and Mounjaro have gained prominence for their effectiveness...
Merck reported second-quarter revenue and adjusted earnings that exceeded Wall Street’s expectations, driven by strong sales from its blockbuster cancer drug Keytruda and other treatments in...